OPERATING SEGMENTS (Tables)

9 Months Ended

Sep. 30, 2023

OPERATING SEGMENTS

Schedule of financial information for each of the entity's reportable segments, including the impact of the preceding changes on previously reported full year 2021 net sales and operating income

	December 31, 2022
	2022 Reported					Fixed	2022 Reported
	Valued at 2022				Currency		Valued at 2023
(millions)	Management Rates		Other		Rate Change		Management Rates
Net Sales
Global Industrial		$6,944.0		$-		($207.7)		$6,736.3
Global Institutional & Specialty		4,480.0		10.2		(75.9)		4,414.3
Global Healthcare & Life Sciences		1,570.0		-		(64.2)		1,505.8
Other		1,355.0		(10.2)		(31.5)		1,313.3
Corporate		124.1		-		(0.4)		123.7
Subtotal at fixed currency rates		14,473.1		-		(379.7)		14,093.4
Effect of foreign currency translation		(285.3)				379.7		94.4
Consolidated reported GAAP net sales		$14,187.8		$-		$-		$14,187.8
Operating Income
Global Industrial		$977.0		$0.8		($42.0)		$935.8
Global Institutional & Specialty		634.5		(1.6)		(11.2)		621.7
Global Healthcare & Life Sciences		205.0		(1.8)		(9.9)		193.3
Other		212.8		2.6		(5.5)		209.9
Corporate		(416.7)		-		2.3		(414.4)
Subtotal at fixed currency rates		1,612.6		-		(66.3)		1,546.3
Effect of foreign currency translation		(50.1)				66.3		16.2
Consolidated reported GAAP operating income		$1,562.5		$-		$-		$1,562.5

Schedule of financial information for each of the entity's reportable segments

	Third Quarter Ended				Nine Months Ended
	September 30				September 30
(millions)	2023		2022		2023		2022
Net Sales
Global Industrial		$1,826.9		$1,763.4		$5,321.8		$4,928.1
Global Institutional & Specialty		1,308.7		1,165.7		3,703.9		3,275.2
Global Healthcare & Life Sciences		400.7		360.1		1,166.8		1,092.7
Other		380.3		350.8		1,072.2		970.1
Corporate		15.0		27.7		55.3		96.1
Subtotal at fixed currency rates		3,931.6		3,667.7		11,320.0		10,362.2
Effect of foreign currency translation		26.5		1.6		61.8		154.4
Consolidated reported GAAP net sales		$3,958.1		$3,669.3		$11,381.8		$10,516.6
Operating Income
Global Industrial		$287.5		$266.6		$758.5		$663.3
Global Institutional & Specialty		249.9		195.2		584.3		452.4
Global Healthcare & Life Sciences		44.0		32.0		111.7		129.1
Other		72.9		63.3		186.4		152.0
Corporate		(92.2)		(76.6)		(248.4)		(263.0)
Subtotal at fixed currency rates		562.1		480.5		1,392.5		1,133.8
Effect of foreign currency translation		3.9		2.5		9.8		29.5
Consolidated reported GAAP operating income		$566.0		$483.0		$1,402.3		$1,163.3